2Ueda K,Sakagami H,Ohtaguro T,et al.Studies on the retention of the mucous-membrane-adhesive anticancer agent hydroxypropylcellulose doxorubicin[J].Eur Urol,1992,21(3):250-252. 被引量：1
3Amling CL.Diagnosis and management of superficial bladdercancer[J].Curr Probl Cancer,2001,25(4):219-278. 被引量：1
4Lamm DL.Clinical evaluation of immunotherapy:are there differences between papillary and flat in situ bladder cancer [J]?Cancer Surv,1998,31:99-108. 被引量：1
9Akaza H,Niijimar T,Hisamatsu T,et al.Comparative investigation on use of (2"R)-4'-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors[J].Urology,1998,32(2):141-145. 被引量：1
10Kobayashi M,Sugaya Y,Yuzawa M,et al.Appropriate intravesical retention time of pirarubicin concentration based on it's level in tumor tissue,anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor[J]. Gan-To-Tyoho,1998,25(11):1771-1774. 被引量：1
